|
CYLD expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.24890000000344E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.353200E-04 |
| Normal-vs-Stage2 |
2.578400E-02 |
| Normal-vs-Stage3 |
1.574050E-02 |
| Normal-vs-Stage4 |
1.116430E-02 |
| Stage1-vs-Stage2 |
5.120800E-01 |
| Stage1-vs-Stage3 |
7.183800E-01 |
| Stage1-vs-Stage4 |
6.572000E-01 |
| Stage2-vs-Stage3 |
4.201200E-01 |
| Stage2-vs-Stage4 |
7.783400E-01 |
| Stage3-vs-Stage4 |
5.082600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.36300000003398E-06 |
| Normal-vs-AfricanAmerican |
5.264000E-01 |
| Normal-vs-Asian |
3.392200E-01 |
| Caucasian-vs-AfricanAmerican |
1.433710E-04 |
| Caucasian-vs-Asian |
9.700600E-01 |
| AfricanAmerican-vs-Asian |
1.473600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.826210E-04 |
| Normal-vs-Female |
8.421300E-04 |
| Male-vs-Female |
9.488400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.501800E-01 |
| Normal-vs-Age(41-60Yrs) |
2.08429999999371E-05 |
| Normal-vs-Age(61-80Yrs) |
1.782320E-03 |
| Normal-vs-Age(81-100Yrs) |
2.081200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.143400E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.209700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.460420E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.008400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.339600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.651000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.272100E-02 |
| Normal-vs-Grade 2 |
1.295710E-03 |
| Normal-vs-Grade 3 |
3.028400E-04 |
| Normal-vs-Grade 4 |
1.718030E-02 |
| Grade 1-vs-Grade 2 |
8.644600E-01 |
| Grade 1-vs-Grade 3 |
9.576400E-01 |
| Grade 1-vs-Grade 4 |
9.457000E-01 |
| Grade 2-vs-Grade 3 |
7.238200E-01 |
| Grade 2-vs-Grade 4 |
6.538000E-01 |
| Grade 3-vs-Grade 4 |
8.445000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.99119999950193E-07 |
| Normal-vs-ccB subtype |
3.896800E-03 |
| ccA subtype-vs-ccB subtype |
8.625800E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.22399999999512E-05 |
| Normal-vs-N1 |
1.538030E-01 |
| N0-vs-N1 |
6.324400E-01 |
|
|
